| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 2.477 | 0 | 782 | 10.108 | 7.036 |
| Total Expenses - EUR | - | - | - | - | - | 2.477 | 2.124 | 994 | 719 | 2.333 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 0 | -2.124 | -213 | 9.389 | 4.704 |
| Net Profit/Loss - EUR | - | - | - | - | - | 0 | -2.124 | -236 | 7.887 | 4.704 |
| Employees | - | - | - | - | - | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cil Med Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 2.542 | 2.510 | 102.874 | 471.642 | 469.006 |
| Current Assets | - | - | - | - | - | 5.994 | 1.974 | 1.738 | 61.847 | 51.256 |
| Inventories | - | - | - | - | - | 820 | 802 | 32 | 32 | 32 |
| Receivables | - | - | - | - | - | 319 | 722 | 550 | 50.800 | 50.637 |
| Cash | - | - | - | - | - | 4.855 | 450 | 1.156 | 11.015 | 588 |
| Shareholders Funds | - | - | - | - | - | 42 | -2.083 | -2.325 | 5.569 | 10.241 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 8.495 | 6.567 | 106.937 | 527.919 | 510.021 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Cil Med Consulting S.r.l.